TrialPloS one2018

Menopausal Hormone Therapy use and breast cancer risk by receptor subtypes: Results from the New South Wales Cancer Lifestyle and EvaluAtion of Risk (CLEAR) study.

Usha Salagame et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.